VECT
VectivBio Holding AG
NASDAQ: VECT · HEALTHCARE · PHARMACEUTICALS
$16.85
+0.00% today
Updated 2026-04-30
Market cap
$1.06B
P/E ratio
—
P/S ratio
21.08x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$0 – $0
Volume
—
VectivBio Holding AG (VECT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | $23.82M | $43.90M | $70.56M | $136.53M | $252.60M |
| Cash & equivalents | $2.13M | $19.81M | $40.17M | $102.71M | $221.42M |
| Current assets | $2.65M | $21.18M | $47.55M | $110.08M | $226.21M |
| Total liabilities | $12.58M | $34.64M | $38.32M | $20.53M | $39.23M |
| Current liabilities | $656000.00 | $32.55M | $34.76M | $17.18M | $24.74M |
| Long-term debt | — | — | — | — | $10.30M |
| Shareholder equity | $11.24M | $9.26M | $32.24M | $116.00M | $213.37M |
| Retained earnings | $0.00 | $-15.71M | $-71.06M | $-132.72M | $-207.76M |
| Accounts receivable | $339000.00 | $252000.00 | $963000.00 | $777000.00 | $1.43M |
| Inventory | — | — | — | $-781000.00 | — |
| Goodwill | $842000.00 | $883000.00 | $901000.00 | $925000.00 | $923000.00 |